These results suggest that high-dose trivalent inactivated influenza vaccine may improve post-vaccine response in immunocompromised patients, including those with RA.
Corinna Panlilio Sison, MD
Director, Clinical Strategy https://www.empr.com
Corinna Panlilio Sison, MD, is the director of clinical strategy for the Haymarket Medical Network, part of the Medical Communications Group of Haymarket Media. She received her BA in biology from the University of Pennsylvania and her MD from the University of Medicine and Dentistry of New Jersey.
